Close Menu

NEW YORK (360Dx) — The US Army has awarded Abbott Laboratories a contract for more than $35.2 million to develop a traumatic brain injury diagnostic assay.

The US Department of Defense said last week that work on the assay will be performed in Abbott Park, Illinois with an estimated completion date of Aug. 31, 2022. Fiscal 2019 research, development, test, and evaluation funds of $12 million were obligated at the time of the award, DoD said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.